We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
DNOW Inc
DNOW
$2.96B
| $608 | ﹤0.01% |
41
-38
| -48% | -$580 |
|
2027
First Bancorp
FBP
$4.24B
| $604 | ﹤0.01% |
29
-1,331
| -98% | -$26.2K |
|
2028
Contango Silver & Gold Inc
CTGO
$675M
| $584 | ﹤0.01% |
+30
| New | +$483 |
|
2029
Teekay
TK
$1.12B
| $561 | ﹤0.01% |
68
-66
| -49% | -$512 |
|
2030
Rapid7
RPD
$930M
| $509 | ﹤0.01% |
+22
| New | +$522 |
|
2031
SandRidge Energy
SD
$523M
| $509 | ﹤0.01% |
47
-10
| -18% | -$102 |
|
2032
Hingham Institution for Saving
HIFS
$656M
| $497 | ﹤0.01% |
2
-1
| -33% | -$242 |
|
|
MDV
2033
DELISTED
Modiv Industrial
MDV
| $479 | ﹤0.01% |
+34
| New | +$505 |
|
|
EBTC
2034
DELISTED
Enterprise Bancorp
EBTC
| $476 | ﹤0.01% |
12
-5
| -29% | -$191 |
|
2035
Box
BOX
$4.78B
| $444 | ﹤0.01% |
13
-5,817
| -100% | -$191K |
|
2036
Ferguson
FERG
$45B
| $436 | ﹤0.01% |
+2
| New | +$368 |
|
2037
Village Super Market
VLGEA
$644M
| $424 | ﹤0.01% |
+11
| New | +$406 |
|
2038
Greif Class B
GEF.B
$4.09B
| $414 | ﹤0.01% |
6
-2
| -25% | -$121 |
|
2039
Triumph Financial Inc
TFIN
$1.72B
| $386 | ﹤0.01% |
7
-16
| -70% | -$891 |
|
2040
Workiva
WK
$4.25B
| $342 | ﹤0.01% |
5
-24,332
| -100% | -$1.67M |
|
2041
X4 Pharmaceuticals
XFOR
$424M
| $283 | ﹤0.01% |
+149
| New | +$610 |
|
2042
NVE Corp
NVEC
$522M
| $221 | ﹤0.01% |
3
| – | – |
|
|
MPTI.WS
2043
DELISTED
M-tron Industries Warrants
MPTI.WS
| $215 | ﹤0.01% |
+207
| New | +$237 |
|
|
GRDN
2044
Guardian Pharmacy Services
GRDN
$2.37B
| $213 | ﹤0.01% |
+10
| New | +$226 |
|
2045
Sylvamo
SLVM
$1.46B
| $200 | ﹤0.01% |
4
-41,575
| -100% | -$2.34M |
|
2046
REX American Resources
REX
$1.35B
| $195 | ﹤0.01% |
8
| – | – |
|
2047
Pacific Biosciences
PACB
$488M
| $170 | ﹤0.01% |
137
-465,121
| -100% | -$537K |
|
2048
Kodiak Gas Services
KGS
$6.11B
| $103 | ﹤0.01% |
3
-11,359
| -100% | -$393K |
|
2049
1-800-Flowers.com
FLWS
$238M
| $64 | ﹤0.01% |
13
-81
| -86% | -$419 |
|
2050
Organon & Co
OGN
$3.62B
| $48 | ﹤0.01% |
5
-83,937
| -100% | -$866K |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.